GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parnell Pharmaceuticals Holdings Ltd (OTCPK:PARNF) » Definitions » Other Long Term Assets

Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) Other Long Term Assets : $0.04 Mil (As of Dec. 2018)


View and export this data going back to 2014. Start your Free Trial

What is Parnell Pharmaceuticals Holdings Other Long Term Assets?

Parnell Pharmaceuticals Holdings's other long-term assets for the quarter that ended in Dec. 2018 was $0.04 Mil.

Parnell Pharmaceuticals Holdings's quarterly other long-term assets declined from Dec. 2016 ($0.53 Mil) to Dec. 2017 ($0.05 Mil) but then stayed the same from Dec. 2017 ($0.05 Mil) to Dec. 2018 ($0.04 Mil).

Parnell Pharmaceuticals Holdings's annual other long-term assets declined from Dec. 2016 ($0.53 Mil) to Dec. 2017 ($0.05 Mil) and declined from Dec. 2017 ($0.05 Mil) to Dec. 2018 ($0.04 Mil).


Parnell Pharmaceuticals Holdings Other Long Term Assets Historical Data

The historical data trend for Parnell Pharmaceuticals Holdings's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Parnell Pharmaceuticals Holdings Other Long Term Assets Chart

Parnell Pharmaceuticals Holdings Annual Data
Trend Jun12 Jun13 Jun14 Dec15 Dec16 Dec17 Dec18
Other Long Term Assets
Get a 7-Day Free Trial 0.03 0.05 0.53 0.05 0.04

Parnell Pharmaceuticals Holdings Semi-Annual Data
Jun12 Jun13 Jun14 Dec15 Dec16 Dec17 Dec18
Other Long Term Assets Get a 7-Day Free Trial 0.03 0.05 0.53 0.05 0.04

Parnell Pharmaceuticals Holdings Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) Business Description

Traded in Other Exchanges
N/A
Address
476 Gardeners Road, Unit 4, Century Estate, Alexandria, Sydney, NSW, AUS, 2015
Parnell Pharmaceuticals Holdings Ltd is an Australia based veterinary pharmaceutical company. It is focused on developing, manufacturing and commercializing animal health solutions. The group manufactures and market products for companion animals and production animals. The firm also has a pipeline of drug products like Zydax, PAR121 and PAR122 and Luminous which covers therapeutic areas in orthopedics, dermatology, and nutraceuticals. The operating segments of the company are Companion animal, Production animal - U.S., Production animal - rest of world and Contract Manufacturing. It operates internationally and generates the majority of the revenue from the Production animal - U.S. segment which covers the group's reproductive hormone portfolio across production animal in the USA.